ABGC Boards Prenatal Exam Study Set
With 100% Correct And Verified Answers
2025
T21TRiskTbyTMaternalTAgeT-TCorrectTAnswer-Age-------------------------------Risk
30T--------------------------------1/952T(.1%)
35T--------------------------------1/385T(.3%)
37T--------------------------------1/227T(.4%)
40T--------------------------------1/106T(.9%)
43T--------------------------------1/50T(3.1%)
RiskTofTAnyTChromTAbnlTbyTMaternalTAgeT-TCorrectTAnswer-
Age--------------------------------Risk
30---------------------------------1/384T(0.3%)
35---------------------------------1/202T(0.5%)
37---------------------------------1/129T(0.8%)
40---------------------------------1/65T(1.6%)
43---------------------------------1/32T(3.1%)
MaternalTSerumTQuadTScreenT-TCorrectTAnswer-
MeasurementTofTbiochemicalTanalytesTinTmaternalTserumTtoTprovideTadjustedTriskTforT
certainTconditions.T
PerformedTduringTsecondTtrimesterTtypicallyT14-21Tweeks
SLOTvsTXLTichthyosis,
SLOThasTpreTandTpostnatalTgrowthTrestrictionsT-TCorrectTAnswer-
DifferentialsTforTextremelyTlowTuE3TonTQUADTscreenTandThowTcanTyouTdifferentiate
Non-disjunctionTinTMeiosisTIT-TCorrectTAnswer-
WhatTisTtheTmostTcommonTcauseTofTaneuploidy
QuadTscreenTconditionsT-TCorrectTAnswer--OpenTNeuralTtubeTdefects
-TDownTSyndrome
-TTrisomyT18
QuadTscreenTanalytesT-TCorrectTAnswer--AFPT(alpha-fetoprotein)T
-hCGT(humanTchorionicTgonadotrophin):T
-uE3T(unconjugatedTestriol):T
,-TInhibin
FactorsTtoTtakeTintoTaccountTforTQuadTScreenT-TCorrectTAnswer-
GestationalTAge:TAsTthisTchangesTsoTdoesTexpectedTvaluesTofTeachTanalyte
Weight:TasTmaternalTweightTincreasesTsoTdoesTbloodTvolume.TDilutesTanalytes
Race:TDifferentTethnicTbackgroundsTcanTaffectedTexpectedTlevels
-Ti.e.TAfricanTAmericanTancestryTtendTtoThaveThigherTAFPTlevels
-DiabeticTstatus:TinsulinTdependentTdiabeticsTtendTtoThaveTlowerTAFP
EffectsTofTinaccurateTdatingTforTQuadTScreenT-TCorrectTAnswer--
OverestimateT(believeTpregnancyTisTfurtherTalong)TcanTleadTtoTfalseTpositiveTforTDown
Tsyndrome.T(OverestimateTbringsTyouTdown)
-
TUnderestimateT(reportedTtoTbeTearlierTthanTitTis)TleadsTtoTfalseTpositiveTforTNTD.TLon
donT(TheTunderTisTtheTtubes)
-TGenerallyTuseTfirstTtrimesterTultrasoundTforTdatingTratherTthanTLMP
IgMT(MostTrecent)
IgGT(ItTisTgone)T-TCorrectTAnswer-
YouTseeTIgMTbutTnotTIgGTisTthisTmoreTconcerningTforTrecentTinfectionsTdueTtoTmatern
alTinfection.
MemoryTdevice
EstriolTandThCGTlowTbutTAFPThighTearly
AllTlow:TLateT-TCorrectTAnswer-PatternsTforTrecentTandTolderTfetalTdemise
TrendsTofTAnalytesTinTSecondTTrimesterT-TCorrectTAnswer-AnalyteTTrend
hCGTDecreasesTasTGATincreases
InhibinTRemainsTStable
uE3TIncreasesTwithTGA
AFPTincreasesTwithTGA
PositiveTQuadTscreenTpatternTIncreasedTriskTforTDownTSyndromeT-TCorrectTAnswer-
HIT(Increased)TLOT(Decreased)
H:ThCG
I:TInhibin
, L:Testriol
O:TAFP
QuadTscreenTpositiveTT18TincreasedTriskT-TCorrectTAnswer-AFP:TLow
hCG:TLow
uE3:TLow
DIA:TN/A
PatternTofTQuadTscreenTwithTabnormalTplacentalTfunctioningT-TCorrectTAnswer-
AFP:THI
hCG:THigh
uE3:TLow
Inhibin:THigh
FirstTTrimesterTScreeningT-TCorrectTAnswer-
MaternalTserumTanalytesTandTultrasoundTareTusedTtoTadjustTaTwoman'sTaTprioriTriskTf
orTaneuploidy.TPerformedTinT1stTtrimesterTusuallyTbetweenT11-13Tweeks
FirstTTrimesterTScreeningTAnalytesT-TCorrectTAnswer-FreeTBeta-hCG
PAPP-A
AFP
AnalytesTareTmeasuresTandTthenTadjustedTforTgestationalTage,TmaternalTweightTandTr
ace
MeasuredTinTMoM-TmultiplesTofTmedian
FirstTTrimesterTScreenTUltrasoundTComponentsT-TCorrectTAnswer-
CrownTtoTRumpTlengthTmeasurement
NuchalTtranslucency
NasalTBone
AdvantagesTofTFirstTTriTScreeningToverTQuadT-TCorrectTAnswer-
IncreasedTsensitivityTforTT21TandTT18
IncludesTT13
RiskTassessmentTearlier
EliminatesTincorrectTdatingTissue
NuchalTtranslucencyT-TCorrectTAnswer-
aTcollectionTofTfluidTthatTextendsTbehindTtheTfetalTneckTandTalongTtheTspineTinTtheTfirs
tTtrimester
With 100% Correct And Verified Answers
2025
T21TRiskTbyTMaternalTAgeT-TCorrectTAnswer-Age-------------------------------Risk
30T--------------------------------1/952T(.1%)
35T--------------------------------1/385T(.3%)
37T--------------------------------1/227T(.4%)
40T--------------------------------1/106T(.9%)
43T--------------------------------1/50T(3.1%)
RiskTofTAnyTChromTAbnlTbyTMaternalTAgeT-TCorrectTAnswer-
Age--------------------------------Risk
30---------------------------------1/384T(0.3%)
35---------------------------------1/202T(0.5%)
37---------------------------------1/129T(0.8%)
40---------------------------------1/65T(1.6%)
43---------------------------------1/32T(3.1%)
MaternalTSerumTQuadTScreenT-TCorrectTAnswer-
MeasurementTofTbiochemicalTanalytesTinTmaternalTserumTtoTprovideTadjustedTriskTforT
certainTconditions.T
PerformedTduringTsecondTtrimesterTtypicallyT14-21Tweeks
SLOTvsTXLTichthyosis,
SLOThasTpreTandTpostnatalTgrowthTrestrictionsT-TCorrectTAnswer-
DifferentialsTforTextremelyTlowTuE3TonTQUADTscreenTandThowTcanTyouTdifferentiate
Non-disjunctionTinTMeiosisTIT-TCorrectTAnswer-
WhatTisTtheTmostTcommonTcauseTofTaneuploidy
QuadTscreenTconditionsT-TCorrectTAnswer--OpenTNeuralTtubeTdefects
-TDownTSyndrome
-TTrisomyT18
QuadTscreenTanalytesT-TCorrectTAnswer--AFPT(alpha-fetoprotein)T
-hCGT(humanTchorionicTgonadotrophin):T
-uE3T(unconjugatedTestriol):T
,-TInhibin
FactorsTtoTtakeTintoTaccountTforTQuadTScreenT-TCorrectTAnswer-
GestationalTAge:TAsTthisTchangesTsoTdoesTexpectedTvaluesTofTeachTanalyte
Weight:TasTmaternalTweightTincreasesTsoTdoesTbloodTvolume.TDilutesTanalytes
Race:TDifferentTethnicTbackgroundsTcanTaffectedTexpectedTlevels
-Ti.e.TAfricanTAmericanTancestryTtendTtoThaveThigherTAFPTlevels
-DiabeticTstatus:TinsulinTdependentTdiabeticsTtendTtoThaveTlowerTAFP
EffectsTofTinaccurateTdatingTforTQuadTScreenT-TCorrectTAnswer--
OverestimateT(believeTpregnancyTisTfurtherTalong)TcanTleadTtoTfalseTpositiveTforTDown
Tsyndrome.T(OverestimateTbringsTyouTdown)
-
TUnderestimateT(reportedTtoTbeTearlierTthanTitTis)TleadsTtoTfalseTpositiveTforTNTD.TLon
donT(TheTunderTisTtheTtubes)
-TGenerallyTuseTfirstTtrimesterTultrasoundTforTdatingTratherTthanTLMP
IgMT(MostTrecent)
IgGT(ItTisTgone)T-TCorrectTAnswer-
YouTseeTIgMTbutTnotTIgGTisTthisTmoreTconcerningTforTrecentTinfectionsTdueTtoTmatern
alTinfection.
MemoryTdevice
EstriolTandThCGTlowTbutTAFPThighTearly
AllTlow:TLateT-TCorrectTAnswer-PatternsTforTrecentTandTolderTfetalTdemise
TrendsTofTAnalytesTinTSecondTTrimesterT-TCorrectTAnswer-AnalyteTTrend
hCGTDecreasesTasTGATincreases
InhibinTRemainsTStable
uE3TIncreasesTwithTGA
AFPTincreasesTwithTGA
PositiveTQuadTscreenTpatternTIncreasedTriskTforTDownTSyndromeT-TCorrectTAnswer-
HIT(Increased)TLOT(Decreased)
H:ThCG
I:TInhibin
, L:Testriol
O:TAFP
QuadTscreenTpositiveTT18TincreasedTriskT-TCorrectTAnswer-AFP:TLow
hCG:TLow
uE3:TLow
DIA:TN/A
PatternTofTQuadTscreenTwithTabnormalTplacentalTfunctioningT-TCorrectTAnswer-
AFP:THI
hCG:THigh
uE3:TLow
Inhibin:THigh
FirstTTrimesterTScreeningT-TCorrectTAnswer-
MaternalTserumTanalytesTandTultrasoundTareTusedTtoTadjustTaTwoman'sTaTprioriTriskTf
orTaneuploidy.TPerformedTinT1stTtrimesterTusuallyTbetweenT11-13Tweeks
FirstTTrimesterTScreeningTAnalytesT-TCorrectTAnswer-FreeTBeta-hCG
PAPP-A
AFP
AnalytesTareTmeasuresTandTthenTadjustedTforTgestationalTage,TmaternalTweightTandTr
ace
MeasuredTinTMoM-TmultiplesTofTmedian
FirstTTrimesterTScreenTUltrasoundTComponentsT-TCorrectTAnswer-
CrownTtoTRumpTlengthTmeasurement
NuchalTtranslucency
NasalTBone
AdvantagesTofTFirstTTriTScreeningToverTQuadT-TCorrectTAnswer-
IncreasedTsensitivityTforTT21TandTT18
IncludesTT13
RiskTassessmentTearlier
EliminatesTincorrectTdatingTissue
NuchalTtranslucencyT-TCorrectTAnswer-
aTcollectionTofTfluidTthatTextendsTbehindTtheTfetalTneckTandTalongTtheTspineTinTtheTfirs
tTtrimester